Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Intervalo de año de publicación
1.
Scand J Med Sci Sports ; 26(10): 1160-70, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26589249

RESUMEN

Although the intake of nonsteroidal anti-inflammatory drugs (NSAIDs) intake by athletes prevents soreness, little is known concerning their role in exercise performance. This study assessed the effects of ibuprofen intake on an exhaustive protocol test after 6 weeks of swimming training in rats. Animals were divided into sedentary and training groups. After training, animals were subdivided into two subsets: saline or ibuprofen. Afterwards, three repeated swimming bouts were performed by the groups. Ibuprofen (15 mg/kg) was administered once a day. Pain measurements were performed and inflammatory and oxidative stress parameters were assayed in cerebral cortex and gastrocnemius muscle. Training, ibuprofen administration, or both combined (P < 0.05; 211 ± 18s, 200 ± 31s, and 279 ± 23s) increased exercise time to exhaustion. Training decreased the acetylcholinesterase (AChE) activity (P < 0.05; 149 ± 11) in cerebral cortex. Ibuprofen intake decreased the AChE activity after exhaustive protocol test in trained and sedentary rats (P < 0.05; 270 ± 60; 171 ± 38; and 273 ± 29). It also prevented neuronal tumor necrosis factor-α (TNF-α) and interleukin (IL 1ß) increase. Fatigue elicited by this exhaustive protocol may involve disturbances of the central nervous system. Additive anti-inflammatory effects of exercise and ibuprofen intake support the hypothesis that this combination may constitute a more effective approach. In addition, ergogenic aids may be a useful means to prevent exercise-induced fatigue.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Fatiga/prevención & control , Ibuprofeno/farmacología , Condicionamiento Físico Animal/fisiología , Resistencia Física/efectos de los fármacos , Acetilcolinesterasa/metabolismo , Animales , Antiinflamatorios no Esteroideos/uso terapéutico , Corteza Cerebral/metabolismo , Fatiga/metabolismo , Ibuprofeno/uso terapéutico , Interleucina-1beta/metabolismo , Masculino , Músculo Esquelético/metabolismo , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Estrés Oxidativo/efectos de los fármacos , Dolor/etiología , Dolor/prevención & control , Dimensión del Dolor , Carbonilación Proteica , Distribución Aleatoria , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Natación/fisiología , Factor de Necrosis Tumoral alfa/metabolismo
2.
J Pediatr ; 123(6): 1005-8, 1993 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7693904

RESUMEN

A 7 1/2-year-old patient with glycogenosis type lb had chronic neutropenia, recurrent bacterial infections, and severe hypoglycemia in spite of continuous nasogastric feeding. She was treated with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation. Absolute neutrophil counts and platelet counts rapidly reached normal values, and infectious episodes were reduced. She resumed oral feeding after transplantation and had no subsequent hypoglycemic episodes.


Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Enfermedad del Almacenamiento de Glucógeno Tipo I/terapia , Factor Estimulante de Colonias de Granulocitos/uso terapéutico , Trasplante de Hígado , Niño , Femenino , Enfermedad del Almacenamiento de Glucógeno Tipo I/cirugía , Humanos , Lenograstim , Proteínas Recombinantes/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA